Shares of Centene (NYSE:CNC) lost ~10% in the early premarket trading on Friday after the Medicaid-driven managed care firm ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Centene Corp (CNC) reports a mixed quarter with revenue growth but faces earnings pressure, while outlining strategic plans for margin recovery and future profitability.

Centene stock tumbled after reporting a surprise Q2 loss, driven by rising medical costs and a weak outlook, shaking ...

Centene’s stock pulled a sharp U-turn into the green, after the health insurer helped assuage investor worries by providing ...

Centene reported a $253 million loss in its second quarter as the provider of government-subsidized health benefits struggles ...

Centene Corporation ( NYSE: CNC) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET a - Corporate Participant v - Corporate Participant Andrew Lynn Asher - Chief Financial Officer Jennifer ...

Evaluate the expected performance of Centene (CNC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for ...

Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription ...

Centene's latest analysis results in a reduction to its previous full-year net risk adjustment revenue transfer expectation of about $1.8 billion, which corresponds to a drop in earnings.

Analysts are estimating that Molina Healthcare will report an earnings per share (EPS) of $5.92. Investors in Molina ...